'김갑성' 기자의 전체기사
-
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance…
SHANGHAI, Aug. 19, 2025 -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: 7MW4911) received IND clearance from the U.S. Food and Drug Administration (FDA). The clearance enables the initiation of Phase I/II study of 7MW4911 to evaluate the safety, pharmacokinetics, and efficacy in patients with advanced colorectal cancer and other advanced gastrointestinal tumors. 7MW4911 is an investigational CDH17-targeting ADC developed using Mabwell's proprietary IDDC™ platform. Its highly
- 김갑성 기자
- 2025-08-19 22:00
-
LabConnect Launches LabConnector™ to Streamline Lab…
New service ensures faster, more accurate data delivery to clients JOHNSON CITY, Tenn., Aug. 19, 2025 -- LabConnect, LLC, a global leader in central laboratory services for clinical trials, today announced the launch of LabConnector™, a powerful new technology solution that transforms the way laboratory data is exchanged and managed for clinical trials. LabConnector standardizes diverse laboratory data into a single HL7 format, enabling true bidirectional data transfer across any participating laboratory. LabConnector is purpose-built for IT teams and data analysts at sp
- 김갑성 기자
- 2025-08-19 21:15
-
WuXi Biologics Reports Solid 2025 Interim Results
[ 메디채널 김갑성 기자 ] Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% EBITDA grew 50.5% YoY and IFRS net profit increased 54.8% YoY Adjusted EBITDA grew 20.6% YoY and adjusted net profit increased 11.6% YoY FY25 group revenue growth target raised to 14% – 16% A first-half record of 86 new integrated projects added, including 2 in late-stage Total integrated projects reached 864, one of the largest portfolios of complex biologics Late-stage and CMO revenue rose 24.9% YoY;
- 김갑성 기자
- 2025-08-19 20:35
-
Nature Medicine Publishes Results of Phase II Study of Sacit…
CHENGDU, China, Aug. 19, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) in combination with PD-L1 monoclonal antibody (mAb) tagitanlimab for the first-line treatment of advanced or metastatic non-small cell lung cancer (NSCLC) have been published in Nature Medicine (Impact Factor: 58.7). The publication highlighted initial findings from the Phase II OptiTROP-Lung01 study, evalua
- 김갑성 기자
- 2025-08-19 20:09
-
Medtronic announces Board appointments and shareho…
Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in 2026 Initiatives follow constructive engagement with Elliott Management GALWAY, Ireland, Aug. 19, 2025 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison
- 김갑성 기자
- 2025-08-19 18:46
-
HoneyNaps Launches Cloud Version of AI Sleep Diagnostic…
[ 메디채널 김갑성 기자 ] HIPAA-compliant cloud-based service provides diagnostic reports via the web with no installation required AI-powered trial service offered, highlighting potential for hospital-specific integration Presented performance of heart rate-based sleep stage estimation algorithm through oral and poster presentations BOSTON, Aug. 19, 2025 -- HoneyNaps, a medical AI diagnostics company, showcased both its technological capabilities and research achievements at SLEEP 2025, the world's largest sleep medicine conference held in Seattle, USA, from June 8 to 11. SLEEP 2
- 김갑성 기자
- 2025-08-19 18:00
-
Dubai Humanitarian: Powerful New Documentary Reveals Worl…
- 'Coming Together: The Dubai Humanitarian Story' provides behind-the-scenes look inside the heart of global disaster response facility - Launches on World Humanitarian Day, 19 August 2025 - First six months of 2025 saw $48.8m humanitarian aid distributed from Dubai Humanitarian, reflected in its Humanitarian Logistics Databank DUBAI, UAE, Aug. 19, 2025 -- Dubai Humanitarian, the world's largest humanitarian logistics hub, has unveiled a new documentary, Coming Together: The Dubai Humanitarian Story - a gripping behind-the-scenes look at the premier disaster response faci
- 김갑성 기자
- 2025-08-19 17:00
-
Dubai Humanitarian: Powerful New Documentary Reveals Worl…
- 'Coming Together: The Dubai Humanitarian Story' provides behind-the-scenes look inside the heart of global disaster response facility - Launches on World Humanitarian Day, 19 August 2025 - First six months of 2025 saw $48.8m humanitarian aid distributed from Dubai Humanitarian, reflected in its Humanitarian Logistics Databank DUBAI, UAE, Aug. 19, 2025 -- Dubai Humanitarian, the world's largest humanitarian logistics hub, has unveiled a new documentary, Coming Together: The Dubai Humanitarian Story - a gripping behind-the-scenes look at the premier disaster response faci
- 김갑성 기자
- 2025-08-19 17:00
-
HEISHA and Unibird Unveil Groundbreaking Drone Defence Tow…
SHENZHEN, China, Aug. 19, 2025 -- In a strategic collaboration, HEISHA Technology and Unibird have launched the Drone Defence Tower (DDT), an advanced autonomous hangar system integrating one search drone and 32 defensive strike FPV drones. This innovative solution combines HEISHA's expertise in multi-layered autonomous drone docks with Unibird's high-performance FPV drone technology, setting new standards in security and defence applications. DDT video link: The HEISHA drone defense tower is a new milestone for autonomous swarm control with Unibird FPV - YouTube The DDT system
- 김갑성 기자
- 2025-08-19 15:08
-
Nilesh Shah joins Illumina as Head of Region, AMEA
SINGAPORE, Aug. 19, 2025 -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment of Nilesh Shah as Head of Region, AMEA, effective immediately. Nilesh brings over 25 years of leadership experience in the medical technology and life sciences industries, having held senior roles at Johnson & Johnson, GE Healthcare and most recently, West Pharmaceutical Services. At West, he served as Vice President & General Manager, Emerging Markets, where he led commercial, operational, and manufacturing st
- 김갑성 기자
- 2025-08-19 14:14
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-08-20_WED
- Global Times: Development opportunities, potential and advantages should be better used 23:58
- First IPO Under GIFT City's IFSC Regime - DRHP Filed; Executive Education Platform Leads the Charge 22:19
- Sisram Medical Reports First-Half 2025 Results: Injectables Surge as AI-Powered EBD Strengthens Segment Positioning 22:14
- TGE alongside with AMTD Obtain Successful Court Decisions against Unauthorised and Infringing Activities in Austria 21:55
- Zylox-Tonbridge Announces 2025 Interim Results: Strong Revenue Growth with Net Profit Surging Over 76% Year-over-Year 21:41
- FOSSIL AND 2025-2026 GLOBAL BRAND AMBASSADOR NICK JONAS RELEASE EXCLUSIVE "MACHINE LUXE" CAPSULE 21:00
- IBM and NASA Release Groundbreaking Open-Source AI Model on Hugging Face to Predict Solar Weather and Help Protect Critical Technology 21:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 08월 21일 01시 40분